Sign up to save your podcasts
Or
Share FDA reverses decision to halt compounding of Terzepetide, for now
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA reverses decision to halt compounding of Terzepetide, for now
Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.
View all episodes
By Bob Weigert & Julie AlmandineDiscussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.